Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: Lancet HIV. 2020 Jun;7(6):e422–e433. doi: 10.1016/S2352-3018(20)30103-X

Figure 3. Coverage (number of events / evaluable sample size) at baseline and end of study in standard-of-care and intervention communities participating in the end of study survey for the Ya Tsie study, overall and by sex and age.

Figure 3.

Figure 3.

Figure 3.

Figure 3.

Figure 3.

A. % HIV-tested or previously diagnosed HIV-positive (among all participants)

B. % previously diagnosed HIV-positive (among all HIV-positive participants)

C. % on ART (among all HIV-positive participants)

D. % virally suppressed and on ART (combined overall UNAIDS target) (among all HIV-positive participants)

E. % circumcised (among HIV-negative male participants aged 16–49 years)